不同水平程序性细胞死亡因子5对重症流行性感冒患者病情的影响

doi:10.3969/j.issn.1674-490X.2022.02.002

医学研究与教育 ›› 2022, Vol. 39 ›› Issue (2): 10-15.DOI: 10.3969/j.issn.1674-490X.2022.02.002

不同水平程序性细胞死亡因子5对重症流行性感冒患者病情的影响

李明¹,苏维²,马士恒¹,王涛³

1.河北大学附属医院感染疾病科, 河北保定 071000;
2.河北大学附属医院检验科, 河北保定 071000;
3. 河北大学附属医院结核科, 河北保定 071000

收稿日期:2021-12-17 出版日期:2022-04-25 发布日期:2022-04-25
通讯作者: 苏维(1979—),男,河北保定人,副主任检验师,硕士,主要从事微生物检验学方面的研究。E-mail: 23195770@qq.com
作者简介:李明(1980—),女,河北保定人,副主任医师,硕士,主要从事感染性疾病方面的研究。 E-mail: lim3212005@126.com
基金资助:
保定市科学技术研究与发展计划项目(2041ZF182);河北大学附属医院青年基金项目(2015Q008)

Effects of PDCD5 on the patients with severe influenza

LI Ming¹, SU Wei², MA Shiheng¹, WANG Tao³

1.Department of Infectious Disease, Affiliated Hospital of Hebei University, Baoding 071000, China; 2.Department of Clinical Laboratory, Affiliated Hospital of Hebei University, Baoding 071000, China; 3. Tuberculosis Department, Affiliated Hospital of Hebei University, Baoding 071000, China

Received:2021-12-17 Online:2022-04-25 Published:2022-04-25

摘要/Abstract

摘要： 目的分析不同血清水平程序性细胞死亡因子5(programmed cell death 5, PDCD5)的流行性感冒(简称流感)患者临床并发症情况以及重症流感患者的影响因素。方法选择2020年6月至12月在河北大学附属医院就诊的流感患者104例作为研究对象,按照入院时血清PDCD5是否大于10 μg/L分为HP组(PDCD5>10 μg/L,n=38)和LP组(PDCD5≤10 μg/L,n=66),分析2组呼吸衰竭、心肌炎、多脏器功能衰竭(multiple organ dysfunction syndrome, MODS)发生情况。按照病情严重程度分级标准分为轻症组(n=61)和重症组(n=43),比较2组的一般资料及临床资料,应用多因素Logistic回归分析影响重症患者的独立危险因素。结果 HP组的呼吸衰竭、心肌炎、MODS发生率均高于LP组(P<0.05)。单因素分析显示,重症组与轻症组的体质量指数、吸烟史、慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)、基质金属蛋白酶9(matrix metalloproteinase 9, MMP9)、氧和指数、淋巴细胞计数、淋巴细胞亚群以及PDCD5水平差异有统计学意义(P<0.05)。多因素Logistic回归分析显示,患者低淋巴细胞计数和CD4⁺T细胞计数、高降钙素原(procalcitonin, PCT)以及PDCD5>10 μg/L是患重型流感的独立危险因素(P<0.05)。结论淋巴细胞、CD4⁺T淋巴细胞和PDCD5、PCT可能影响流感患者的病情,流感患者的诊治过程中应重视上述指标。

关键词: 流行性感冒, 程序性细胞死亡分子5, 淋巴细胞亚群, 降钙素原

Abstract: Objective To analyze the clinical complications of patients with influenza pneumonia in different PDCD5 levels and the risk factors of severe influenza patients. Methods 104 patients with influenza treated in our hospital from June 2020 to December 2020 were divided into HP group(PDCD5>10 μg/L, n=38)and LP group(PDCD5≤10 μg/L, n=66). They were divided into mild disease group(n=61)and severe disease group(n=43)according to the severity. The incidence of respiratory failure, cardiac myositis and multiple organ failure(MODS)were analyzed. The general and clinical data of the two groups were compared, and the independent risk factors of severe patients were analyzed with multivariate logistic regression. Results The incidence of respiratory failure, myocarditis and MODS in HP group were higher than those in LP group(P<0.05). Univariate analysis showed that there were significant differences between severe group and mild group in BMI, smoking history, COPD, MMP9, PaO₂/FiO₂, lymphocyte, lymphocyte subsets and PDCD5 level(P<0.05). Multivariate logistic regression analysis showed that low lymphocyte and CD4⁺T cell, high PCT and PDCD5>10 μg/L were independent risk factors for patients with severe influenza(P<0.05). Conclusion Lymphocytes, CD4⁺T lymphocytes, PDCD5 and PCT may affect the disease progression and more attention should be paid to those indexes.

Key words: influenza, programmed cell death molecule 5, lymphocyte subsets, procalcitonin

中图分类号:

李明,苏维,马士恒,王涛. 不同水平程序性细胞死亡因子5对重症流行性感冒患者病情的影响[J]. 医学研究与教育, 2022, 39(2): 10-15.

LI Ming, SU Wei, MA Shiheng, WANG Tao. Effects of PDCD5 on the patients with severe influenza[J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(2): 10-15.

参考文献

[1] LI G X, YILMAZ M, KOJICIC M, et al. Outcome of critically ill patients with influenza virus infection[J]. J Clin Virol, 2009, 46(3): 275-278. DOI: 10.1016/j.jcv.2009.07.015.
[2] 龚慧,申鑫,严涵,等. 2006—2019年中国季节性流感疾病负担估计[J].中华医学杂志, 2021, 101(8): 560-567. DOI: 10.3760/cma.j.cn112137-20201210-03323.
[3] 中华人民共和国国家卫生健康委员会.流行性感冒诊疗方案(2020年版)[J].全科医学临床与教育, 2020, 18(12): 1059-1063. DOI: 10.13558/j.cnki.issn1672-3686.2020.012.002.
[4] 张代涛,刘重程,赵小娟,等.北京市2018—2019流行季流感的发病率和住院率研究[J].国际病毒学杂志, 2020, 27(1): 23-26. DOI: 10.3760/cma.j.issn.1673-4092.2020.01.006.
[5] TAVARES L P, TEIXEIRA M M, GARCIA C C. The inflammatory response triggered by Influenza virus: a two edged sword[J]. Inflamm Res, 2017, 66(4): 283-302. DOI: 10.1007/s00011-016-0996-0.
[6] CHEN C, SUN W, CHEN J, et al. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: a retrospective small-scale study[J]. Exp Ther Med, 2017, 13(4): 1490-1494. DOI: 10.3892/etm.2017.4144.
[7] 耿陶然,韩扬,邱志峰,等.重症流行性感冒患者T淋巴细胞与预后研究[J]. 中华内科杂志, 2020, 59(3): 200-206. DOI: 10.3760/cma.j.issn.0578-1426.2020.03.006.
[8] 陈凤欣,赵银连,李蕴铷,等.甲型H1N1流感患者的免疫学特征分析[J].中国全科医学, 2010, 13(19): 2118-2119. DOI: 10.3969/j.issn.1007-9572.2010.19.021.
[9] ROBERTS N J Jr. Diverse and unexpected roles of human monocytes/macrophages in the immune response to influenza virus[J]. Viruses, 2020, 12(4): 379. DOI: 10.3390/v12040379.
[10] YANG K, ZHANG N, GAO C C, et al. Risk factors for hospital-acquired influenza A and patient characteristics: a matched case-control study[J]. BMC Infect Dis, 2020, 20(1): 863. DOI: 10.1186/s12879-020-05580-9.
[11] 吉茂礼,程涛.甲型H1N1流感病毒RNA定量分析在轻型与肺炎患者中的应用[J].陕西医学杂志, 2018, 47(11): 1503-1506. DOI: 10.3969/j.issn.1000-7377.2018.11.041.
[12] 钱永兵,谢晖,田锐,等.早期免疫功能麻痹在重症甲型H1N1流感中的临床意义[J].中华危重病急救医学, 2017, 29(7): 581-585. DOI: 10.3760/cma.j.issn.2095-4352.2017.07.002.
[13] 张玮宸,裴玉芳.流感患者外周血C反应蛋白、淋巴细胞与肺炎严重度指数的相关性分析[J].武警医学, 2020, 31(6): 486-489. DOI: 10.14010/j.cnki.wjyx.2020.06.008.
[14] 李靖,屠蒙,徐喆选,等.T淋巴细胞亚群对重症甲型流感患者预后的评估价值[J].医学研究生学报, 2019, 32(11): 1174-1178. DOI: 10.16571/j.cnki.1008-8199.2019.11.011.
[15] 杨丰赫,叶菁菁,郑铭.程序性细胞死亡分子5(PDCD5)研究进展[J].生理科学进展, 2021, 52(1): 1-6.
[16] ZHUGE C J, SUN X J, CHEN Y Y, et al. PDCD5 functions as a regulator of p53 dynamics in the DNA damage response[J]. J Theor Biol, 2016, 388: 1-10. DOI: 10.1016/j.jtbi.2015.09.025.
[17] LI P H, FEI H X, WANG L H, et al. PDCD5 regulates cell proliferation, cell cycle progression and apoptosis[J]. Oncol Lett, 2018, 15(1): 1177-1183. DOI: 10.3892/ol.2017.7401.
[18] 李明,苏维,马士恒,等.甲型H1N1型流感患者外周血程序化细胞死亡分子5表达水平及其与疾病严重程度的相关性[J].医学研究生学报, 2018, 31(6): 636-640. DOI: 10.16571/j.cnki.1008-8199.2018.06.015.

不同水平程序性细胞死亡因子5对重症流行性感冒患者病情的影响

Effects of PDCD5 on the patients with severe influenza

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 10

编辑推荐

Metrics

本文评价

[1]	马士恒,李明. 柯萨奇病毒A组16型的研究进展[J]. 医学研究与教育, 2020, 37(6): 7-13.
[2]	马士恒，李明. 丙种球蛋白在重症手足口病患儿中的应用[J]. 医学研究与教育, 2015, 32(5): 1-3.
[3]	南凯，朱太平，刘斯文，刘素梅，李晓伟，郝利锋. 社区获得性肺炎抗感染药物的应用分析[J]. 医学研究与教育, 2015, 32(1): 76-79.
[4]	马士恒，李明. 乙肝病毒既往感染者血清 HBV DNA 检测[J]. 医学研究与教育, 2014, 31(5): 13-15.
[5]	苏春华. 43 例大学生水痘患者防治及护理[J]. 医学研究与教育, 2014, 31(5): 43-45.
[6]	张进国,张保宗,张雁,王彦辉,孙晓丽,于健. 抗结核FDC与板式组合药治疗初治肺结核转归对比分析[J]. 医学研究与教育, 2014, 31(1): 28-32.
[7]	马士恒,杨彦改,常亚青,谢晓华. 肝病患者血清腺苷脱氨酶检测的临床意义[J]. 医学研究与教育, 2013, 30(1): 33-35.
[8]	边静,张锋,陈博. 丙型病毒性肝炎的研究进展[J]. 医学研究与教育, 2012, 29(1): 75-78.
[9]	孙春伟. 阿德福韦酯联合干扰素α治疗慢性乙型病毒性肝炎[J]. 医学研究与教育, 2011, 28(4): 21-23,37.
[10]	张庆哲,朱秋群,马士恒,黄荣香,齐振平. 慢性乙型病毒性肝炎患者健康教育的研究进展[J]. 医学研究与教育, 2010, 27(2): 78-82.